Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 44 articles:
HTML format



Single Articles


    November 2022
  1. PIOVEZANI RAMOS G, Camilleri M
    Current and Future Therapeutic Options for Irritable Bowel Syndrome with Diarrhea and Functional Diarrhea.
    Dig Dis Sci. 2022 Nov 14. pii: 10.1007/s10620-022-07700.
    PubMed     Abstract available


  2. OH CJ, Rezaie A
    Small Is Big: Why the Analysis of the Fecal Microbiome Provides Little Important Information on IBS Severity.
    Dig Dis Sci. 2022;67:4974-4975.
    PubMed    


    July 2022
  3. HOU Y, Dong L, Lu X, Shi H, et al
    Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome.
    Dig Dis Sci. 2022 Jul 25. pii: 10.1007/s10620-022-07588.
    PubMed     Abstract available


    June 2022
  4. OLMOS JI, Piskorz MM, Litwin N, Schaab S, et al
    Exocrine Pancreatic Insufficiency is Undiagnosed in Some Patients with Diarrhea-Predominant Irritable Bowel Syndrome Using the Rome IV Criteria.
    Dig Dis Sci. 2022 Jun 15. pii: 10.1007/s10620-022-07568.
    PubMed     Abstract available


  5. LEE AA, McNabb-Baltar J
    Undiagnosed Exocrine Pancreatic Insufficiency in Diarrhea-Predominant Irritable Bowel Syndrome.
    Dig Dis Sci. 2022 Jun 15. pii: 10.1007/s10620-022-07574.
    PubMed    


    May 2022
  6. WANG T, Rijnaarts I, Hermes GDA, de Roos NM, et al
    Fecal Microbiota Signatures Are Not Consistently Related to Symptom Severity in Irritable Bowel Syndrome.
    Dig Dis Sci. 2022 May 27. pii: 10.1007/s10620-022-07543.
    PubMed     Abstract available


  7. BRAVO-VAZQUEZ LA, Medina-Rios I, Marquez-Gallardo LD, Reyes-Munoz J, et al
    Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review.
    Dig Dis Sci. 2022 May 4. pii: 10.1007/s10620-022-07516.
    PubMed     Abstract available


  8. YAO C, Li Y, Luo L, Xie F, et al
    Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China.
    Dig Dis Sci. 2022 May 3. pii: 10.1007/s10620-022-07500.
    PubMed     Abstract available


    April 2022
  9. BRAY NA, Koloski NA, Jones MP, Do A, et al
    Evaluation of a Multidisciplinary Integrated Treatment Approach Versus Standard Model of Care for Functional Gastrointestinal Disorders (FGIDS): A Matched Cohort Study.
    Dig Dis Sci. 2022 Apr 1. pii: 10.1007/s10620-022-07464.
    PubMed     Abstract available


    March 2022
  10. GANJI L, Shirazi MH, Ebrahimi-Daryani N, Eslami P, et al
    Carriage of CdtB Encoding Campylobacter spp., Salmonella enterica, and Yersinia entercolitica in Patients with Gastroenteritis and Irritable Bowel Syndrome.
    Dig Dis Sci. 2022 Mar 31. pii: 10.1007/s10620-022-07468.
    PubMed     Abstract available


    February 2022
  11. LIU H, Zou Y, Kan Y, Li X, et al
    Prevalence and Influencing Factors of Irritable Bowel Syndrome in Medical Staff: A Meta-Analysis.
    Dig Dis Sci. 2022 Feb 17. pii: 10.1007/s10620-022-07401.
    PubMed     Abstract available


  12. VIJAYVARGIYA P, Breen-Lyles M, Nord SL, Maselli D, et al
    Safety and Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome-Diarrhea With or Without Bile Acid Diarrhea: Open-Label Study.
    Dig Dis Sci. 2022 Feb 5. pii: 10.1007/s10620-022-07379.
    PubMed     Abstract available


  13. SHAH ED
    Delta Variant: Expanding the Indication for Eluxadoline to Bile Acid Diarrhea.
    Dig Dis Sci. 2022 Feb 5. pii: 10.1007/s10620-022-07386.
    PubMed    


    January 2022
  14. SHAH ED
    Zinc Deficiency and Intestinal Permeability in the Context of Rational Diagnostic and Drug Development for Diarrhea-Predominant Irritable Bowel Syndrome.
    Dig Dis Sci. 2022 Jan 11. pii: 10.1007/s10620-021-07369.
    PubMed    


  15. REZAZADEGAN M, Soheilipour M, Tarrahi MJ, Amani R, et al
    Correlation Between Zinc Nutritional Status with Serum Zonulin and Gastrointestinal Symptoms in Diarrhea-Predominant Irritable Bowel Syndrome: A Case-Control Study.
    Dig Dis Sci. 2022 Jan 6. pii: 10.1007/s10620-021-07368.
    PubMed     Abstract available


    September 2021
  16. CHAUHAN A, Das P, Singh A, Dutta R, et al
    Pan-Gastrointestinal Tract Mucosal Pathologies in Patients with Celiac Disease with the Demonstration of IgA Anti-Transglutaminase Mucosal Deposits: A Case-Control Study.
    Dig Dis Sci. 2021 Sep 9. pii: 10.1007/s10620-021-07246.
    PubMed     Abstract available


    August 2021
  17. CHUAH KH, Wong MS, Tan PO, Lim SZ, et al
    Small Intestinal Bacterial Overgrowth In Various Functional Gastrointestinal Disorders: A Case-Control Study.
    Dig Dis Sci. 2021 Aug 21. pii: 10.1007/s10620-021-07227.
    PubMed     Abstract available


  18. SHAH A, Gurusamy SR, Hansen T, Callaghan G, et al
    Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia.
    Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07149.
    PubMed     Abstract available


    July 2021
  19. DEUTSCH D, Bouchoucha M, Uzan J, Raynaud JJ, et al
    Abdominal Pain Severity Is Mainly Associated with Bloating Severity in Patients with Functional Bowel Disorders and Functional Abdominal Pain.
    Dig Dis Sci. 2021 Jul 29. pii: 10.1007/s10620-021-07175.
    PubMed     Abstract available


  20. ANYANE-YEBOA A, Li B, Traboulsi C, Erondu AI, et al
    Black Race and Public Insurance Are Predictive of Inappropriate Evaluation of Iron Deficiency Anemia and Diarrhea.
    Dig Dis Sci. 2021;66:2200-2206.
    PubMed     Abstract available


    June 2021
  21. ISHIHARA J, Arai K, Kudo T, Nambu R, et al
    Serum Zinc and Selenium in Children with Inflammatory Bowel Disease: A Multicenter Study in Japan.
    Dig Dis Sci. 2021 Jun 8. pii: 10.1007/s10620-021-07078.
    PubMed     Abstract available


    March 2021
  22. SHAH ED, Brenner DM, Chen VL
    Baseline Predictors of Discontinuation of Prescription Drug Therapy for IBS-C: Cohort Analysis at an Integrated Healthcare System.
    Dig Dis Sci. 2021 Mar 29. pii: 10.1007/s10620-021-06963.
    PubMed     Abstract available


  23. LEVINTHAL DJ
    Now Trending: Using Google Trends to Complement Traditional Epidemiological Methods Used for IBS Research.
    Dig Dis Sci. 2021;66:662-664.
    PubMed    


    January 2021
  24. SHAH ED, Chang L, Lembo A, Staller K, et al
    Price Is Right: Exploring Prescription Drug Coverage Barriers for Irritable Bowel Syndrome Using Threshold Pricing Analysis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06806.
    PubMed     Abstract available


    October 2020
  25. NORWOOD DA, Dominguez LB, Paredes AA, Montalvan EE, et al
    Prevalence and Associated Dietary Factors of Rome IV Functional Gastrointestinal Disorders in Rural Western Honduras.
    Dig Dis Sci. 2020 Oct 22. pii: 10.1007/s10620-020-06639.
    PubMed     Abstract available


  26. BOUCHOUCHA M, Fysekidis M, Deutsch D, Bejou B, et al
    Biopsychosocial Model and Perceived Constipation Severity According to the Constipation Phenotype.
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06654.
    PubMed     Abstract available


    August 2020
  27. BIELEFELDT K
    Perceived Barriers to Treatment in Persons Treated for Functional Gastrointestinal Disease with Constipation.
    Dig Dis Sci. 2020 Aug 20. pii: 10.1007/s10620-020-06544.
    PubMed     Abstract available


  28. KUMRAL D, Syed S
    Celiac Disease Screening for High-Risk Groups: Are We Doing It Right?
    Dig Dis Sci. 2020;65:2187-2195.
    PubMed     Abstract available


    June 2020
  29. GUTIN LS, Lam AY, Velayos FS, Santos SA, et al
    Going Viral: Management of IBD in the Era of the COVID-19 Pandemic.
    Dig Dis Sci. 2020;65:1571-1575.
    PubMed    


    May 2020
  30. RANGAN V, Nee J, Singh P, Ballou S, et al
    Fecal Urgency: Clinical and Manometric Characteristics in Patients With and Without Diarrhea.
    Dig Dis Sci. 2020 May 28. pii: 10.1007/s10620-020-06349.
    PubMed     Abstract available


  31. FLANAGAN R, Kuo B, Staller K
    Utilizing Google Trends to Assess Worldwide Interest in Irritable Bowel Syndrome and Commonly Associated Treatments.
    Dig Dis Sci. 2020 May 2. pii: 10.1007/s10620-020-06290.
    PubMed     Abstract available


    April 2020
  32. WEINSTOCK LB, Pace LA, Rezaie A, Afrin LB, et al
    Mast Cell Activation Syndrome: A Primer for the Gastroenterologist.
    Dig Dis Sci. 2020 Apr 23. pii: 10.1007/s10620-020-06264.
    PubMed     Abstract available


  33. WAGNER BA, Zork N, Blackett JW, Green PHR, et al
    Characteristics and Maternal-Fetal Outcomes of Pregnant Women Without Celiac Disease Who Avoid Gluten.
    Dig Dis Sci. 2020 Apr 1. pii: 10.1007/s10620-020-06232.
    PubMed     Abstract available


    March 2020
  34. BALLOU S, Katon J, Rangan V, Cheng V, et al
    Brief Behavioral Therapy for Insomnia in Patients with Irritable Bowel Syndrome: A Pilot Study.
    Dig Dis Sci. 2020 Mar 9. pii: 10.1007/s10620-020-06182.
    PubMed     Abstract available


  35. SORESI M, Incandela S, Mansueto P, Incandela G, et al
    Gynecological Disorders in Patients with Non-celiac Wheat Sensitivity.
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06184.
    PubMed     Abstract available


    February 2020
  36. ZHANG Y, Wang X, Wang S, Yan Z, et al
    Heat Shock Protein 27 Regulates the Inflammatory Response of Intestinal Epithelial Cells by the Nuclear Factor-kappaB Pathway.
    Dig Dis Sci. 2020 Feb 20. pii: 10.1007/s10620-020-06074.
    PubMed     Abstract available


  37. PIMENTEL M, Lembo A
    Microbiome and Its Role in Irritable Bowel Syndrome.
    Dig Dis Sci. 2020 Feb 5. pii: 10.1007/s10620-020-06109.
    PubMed     Abstract available


  38. CHIARIONI G, Marconato E
    Concise Commentary: Prebiotic, Probiotic, Whatever-It's All Good for IBS-C.
    Dig Dis Sci. 2020;65:550.
    PubMed    


    January 2020
  39. WANG KL, Hsia SM, Wang PS, Lin PH, et al
    Disturbed Gastrointestinal Contractility in a Polycystic Ovary Syndrome Rat Model.
    Dig Dis Sci. 2020 Jan 2. pii: 10.1007/s10620-019-06001.
    PubMed     Abstract available


    December 2019
  40. D'SILVA A, MacQueen G, Nasser Y, Taylor LM, et al
    Yoga as a Therapy for Irritable Bowel Syndrome.
    Dig Dis Sci. 2019 Dec 12. pii: 10.1007/s10620-019-05989.
    PubMed     Abstract available


    November 2019
  41. GU P, Patel D, Lakhoo K, Ko J, et al
    Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis.
    Dig Dis Sci. 2019 Nov 21. pii: 10.1007/s10620-019-05967.
    PubMed     Abstract available


    October 2019
  42. ALLEGRETTI JR, Marcus J, Storm M, Sitko J, et al
    Clinical Predictors of Recurrence After Primary Clostridioides difficile Infection: A Prospective Cohort Study.
    Dig Dis Sci. 2019 Oct 30. pii: 10.1007/s10620-019-05900.
    PubMed     Abstract available


  43. ZIKOS TA, Hendler S, Clarke JO, Triadafilopoulos G, et al
    Reduction in Hospitalizations for Esophageal Reflux in a Decade with Minimal Increases in Other Functional and Motor Disorders.
    Dig Dis Sci. 2019 Oct 16. pii: 10.1007/s10620-019-05895.
    PubMed     Abstract available


  44. AMIEVA-BALMORI M, Coss-Adame E, Rao NS, Davalos-Pantoja BM, et al
    Diagnostic Utility of Carbohydrate Breath Tests for SIBO, Fructose, and Lactose Intolerance.
    Dig Dis Sci. 2019 Oct 15. pii: 10.1007/s10620-019-05889.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: